Nonparametric modeling and analysis of association between Huntington's disease onset and CAG repeats

Yanyuan Ma1, Yuanjia Wang

  • 1Department of Statistics, Texas A&M University, College Station, TX, U.S.A.

Statistics in Medicine
|September 13, 2013
PubMed

Insights

This study introduces a flexible statistical method to better predict Huntington's disease (HD) onset age using CAG repeat length. The new approach improves accuracy by not assuming a specific relationship between genetic factors and disease timing.

Area of Science:

  • Genetics
  • Neurodegenerative Disorders
  • Biostatistics

Background:

  • Huntington's disease (HD) is a genetic neurodegenerative disorder caused by CAG repeat expansion on chromosome 4.
  • Longer CAG repeat lengths are generally associated with earlier HD onset.
  • Existing models often use restrictive logistic assumptions for the relationship between CAG length and HD onset.

Purpose of the Study:

  • To develop a semiparametric statistical method to model the age of Huntington's disease onset.
  • To relax the rigid parametric assumptions of previous models relating CAG repeat length to HD onset.
  • To incorporate family history data and handle censored age-at-onset information.

Main Methods:

  • Proposed a semiparametric estimation approach using local kernel and backfitting procedures.
  • Developed methodology for mixture data, accommodating individuals at risk and those potentially risk-free.
  • Accounted for censored data and additional covariates beyond CAG repeat length.

Main Results:

  • The study derived the asymptotic distribution of the proposed semiparametric estimator.
  • The methods were applied to the Cooperative Huntington's Observational Research Trial (COHORT) data.
  • Successfully estimated the Huntington's disease onset distribution using genetic and family history information.

Conclusions:

  • The developed semiparametric method offers a more flexible and robust way to analyze Huntington's disease onset.
  • This approach improves the understanding of the relationship between genetic factors and disease progression.
  • The methodology is valuable for analyzing complex genetic disorders with available family data.

Related Concept Videos

Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...